Skip to main content

208 publications

Name Date Type Actions

2023 ANNUAL RESULTS

Annual sales: €529m (stable at constant exchange rates)
Essentials sales: €313m (+4.5% at constant exchange rates)
Net income - Group share: €56m (10.5% of sales)
EBITDA: €113m (21.3% of sales)
Free cash-flow: €89m

20/03/2024 Public releases

Buyback programs – January 2024

Monthly communication regarding buyback programs

02/02/2024 Description of buyback programs

Annual sales 2023: €529 million

Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates)

24/01/2024 Public releases

Buyback programs - November 2023

Monthly communication regarding buyback programs

04/12/2023 Description of buyback programs

Buyback programs - december 2023

Monthly communication regarding buyback programs

03/12/2023 Description of buyback programs

Buyback programs - october 2023

Monthly communication regarding buyback programs

06/11/2023 Description of buyback programs

Sales 3rd quarter 2023: 136M€

The Vetoquinol Group posted sales of €136 million in Q3 2023, up +1.3% on a reported basis and +5.1% at constant exchange rates. Over the same period, Vetoquinol recorded a negative currency impact of -€5 million, linked to the Americas and Asia Pacific/Rest of World territories.

26/10/2023 Public releases

Buyback programs - September 2023 (french)

Monthly communication regarding buyback programs

04/10/2023 Description of buyback programs

Buyback programs - August 2023 (french)

Monthly communication regarding buyback programs

12/09/2023 Description of buyback programs

2023 HALF-YEAR RESULTS

Sales: €256m (-5.4% as reported)
Essentials products sales: €151m (59% of Group sales)
Net income - Group share: €32m (12.6% of sales)
EBITDA*: €54m (20.9% of sales)
Cash-flow generation: €31m

07/09/2023 Public releases